Will CMS issue OBBBA Medicaid work requirements guidance or approve state waiver applications by Q3 2026?

CEO Zubretsky's direct reference to 'the guidance from CMS affords States some flexibility' on the Q1 call is explicit management acknowledgment that CMS guidance exists as of April 2026. Nebraska proceeding with work requirements mid-2026 requires CMS administrative action — states cannot unilaterally implement OBBBA work requirements. With 5+ months until Sept 30 resolution and the OR structure (formal guidance OR 1115 waiver in CA/TX/WA/NY), the trajectory strongly favors YES. The 10% residual uncertainty is the 'formal' qualifier — current CMS action may be sub-regulatory.

Two-channel confirmation of CMS activity: (1) explicit CEO reference to CMS guidance enabling state flexibility, (2) first state (Nebraska) proceeding to implementation. Even if current guidance is informal or sub-regulatory, the CMS administrative machine clearly must formalize before Dec 2026 statutory effective date — placing formal guidance or early waiver approvals well before Sept 30 2026. Remaining uncertainty weighted toward whether formal qualifier is met or whether CA/TX/WA/NY specifically see waiver approval (Nebraska alone doesn't resolve).

Bayesian reasoning: Prior was 78% in Feb with no observed CMS action. Q1 update provides strong positive evidence (CEO explicit quote + Nebraska implementation), lifting to mid-80s%. Key risk adjustment: the 'formal' qualifier in the resolution criteria matters. Sub-regulatory guidance, State Medicaid Director letters, or State Plan Amendments may not meet the 'formal guidance' bar if interpreted strictly. Also notable: community engagement requirements 'rules still unclear' suggests CMS action is partial, not comprehensive. 86% balances the strong circumstantial evidence against strict interpretation risk.

Management is effectively confirming CMS guidance exists by referencing it in earnings commentary. States don't implement federal requirements off vapor — Nebraska going mid-2026 requires a documented regulatory pathway. CMS has statutory obligation to publish implementation guidance before Dec 2026 effective date. By Sept 30 2026, the likelihood of either (a) formal published guidance or (b) at least one 1115 waiver approval for CA/TX/WA/NY is very high. Main counter: CA and NY are politically resistant and may file waivers targeting 2027+ implementation — but even filing-stage waivers under CMS review could qualify depending on interpretation.

Strong prior from Q1 evidence but tempered by two specific risks: (1) the resolution criteria require 'formal' guidance — sub-regulatory letters or FAQs might not qualify; (2) 1115 waiver approval component is specifically CA/TX/WA/NY, and those states have slower political dynamics than Nebraska. Management's softer OBBBA tone on the call ('minor impact gradually through 2027-2028') could reflect expected formal guidance being permissive — supporting YES resolution. Balancing: 85% captures high probability with meaningful uncertainty on formal qualifier.

Combining: (1) CEO direct quote referencing 'guidance from CMS' on April call, (2) Nebraska going mid-2026 (which cannot happen without CMS), (3) statutory Dec 2026 effective date creating CMS obligation, (4) 5+ months of runway to Sept 30, (5) OR resolution structure. The weight of evidence overwhelmingly supports YES. The sole downside risk is narrow: the specific 'formal' qualifier combined with CA/TX/WA/NY specificity. But 'formal guidance' would include CMS State Medicaid Director letters, which are routine sub-regulatory documents published on CMS.gov — highly likely by Sept 30 given management referencing CMS guidance already.

CEO directly confirmed CMS guidance exists. Nebraska first state going mid-2026. Dec 2026 statutory deadline approaching. By Sept 30 2026, CMS formal guidance very likely to be published.

Strong directional evidence but formal guidance qualifier and CA/TX/WA/NY specificity introduce risk. Nebraska alone doesn't resolve. Still high probability given CMS timeline pressure.

Q1 evidence significantly strengthens YES case. Management references CMS guidance directly; Nebraska implementing. OR resolution structure lowers bar. 87% reflects high confidence with residual interpretation risk on formal qualifier.